Question
The Theranos-Walgreens case serves as a cautionary tale for businesses. It underscores the importance of due diligence before entering into partnerships or making significant investments. Companies should thoroughly vet potential partners, validate their claims, and ensure they have a solid, proven product or service. It also highlights the need for transparency and ethical business practices. Misrepresentation and deceit can lead to severe consequences, including loss of trust, legal issues, and financial downfall. Lastly, it reminds businesses to be wary of quick deals that seem too good to be true, as they often are.
This question was asked on:
In 2010 Theranos started courting Walgreens, one of America's largest pharmacy store chains, promising to run blood tests within minutes from a few drops of patient blood. The Walgreens innovation team immediately saw huge potential in a partnership. Both companies agreed to run a pilot project where Theranos readers would be placed in 30 to 90 Walgreens stores within a year. Walgreens committed to purchase $50 million worth of Theranos Cartridges and loaned $25 million to Theranos. This was unusually fast deal-making for the conservative company.
Receive new free presentations every Monday to your inbox.
Full content, complete versions — No credit card required.
